Polymorphisms of Homologous Recombination RAD51, RAD51B, XRCC2, and XRCC3 Genes and the Risk of Prostate Cancer

Table 4

Distribution of genotypes and allele frequency in the RAD51, RAD51B, XRCC2, and XRCC3 loci among prostate cancer patients.

Gene	Genotype/allele	Prostate cancer patients; ()	Control group; ()
RAD51; rs1801320	GG	66	172	0.017
	GC	27	37
	CC	8	7
	G	159	381	0.002
	C	43	51
rs1801321	GG	39	67	0.392
	TG	4	8
	TT	58	141
	G	82	421	0.058
	T	120	290
RAD51B; rs10483813	TT	56	134	0.350
	TA	40	68
	AA	5	14
	T	152	336	0.481
	A	50	96
rs3784099	GG	49	122	0.225
	GA	41	80
	AA	11	14
	G	139	324	0.102
	A	63	108
XRCC2; rs3218536	GG	90	196	0.648
	GA	11	20
	AA	0	0
	G	191	412	0.800
	A	11	20
XRCC3; rs861539	CC	54	119	0.776
	CT	34	75
	TT	13	22
	C	142	313	0.574
	T	60	119